Chicago Atlantic BDC LIEN 深 滬
等待開盤 12-25 09:30:00 美东时间
10.48
+0.040
+0.38%
華盛通- 最 高10.596
- 今 開10.37
- 成交量 4.74万股
- 最 低 10.37
- 昨 收 10.44
- 總市值 2.39亿
- 52周最高 11.63
- 市盈率 靜 11.27
- 換手率 0.21%
- 52周最低 9.02
- 委 比 49.59%
- 總股本 2282.06万
- 歷史最高 12.02
- 量 比 1.17
- 振 幅 2.16%
- 歷史最低 4.08
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Chicago Atlantic BDC Finalizes Name Change and Bylaws Update
Chicago Atlantic BDC ( ($LIEN) ) has issued an announcement. On December 17, 20...
12-20 06:56
Chicago Atlantic BDC Ends Dividend Reinvestment Plan
Chicago Atlantic BDC ( ($LIEN) ) has shared an announcement. Chicago Atlantic B...
12-02 06:48
Chicago Atlantic BDC, Inc. to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Chicago Atlantic BDC, Inc. will participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025, in Boca Raton, FL. Dino Colonna, the Company's President, will host investor meetings and deliver a presentation at 3:00 PM ET on December 3. A high-definition webcast of the presentation will be available on the Company's website and Noble Capital Markets' Conference website the following day, and archived fo...
11-21 12:00
Chicago Atlantic BDC reports Q3 results
Chicago Atlantic BDC press release (LIEN): Q3 total gross investment income of $15.1 million. Interest income accounted for $13.8 million, of which $1.9 million was related to one-time pre-payment pre...
11-14 19:34
Chicago Atlantic BDC declares $0.34 dividend
Chicago Atlantic BDC (LIEN) declares $0.34/share quarterly dividend, in line with previous. Forward yield 13.55% Payable Jan. 15; for shareholders of record Dec. 31; ex-div Dec. 31. See LIEN Dividend ...
11-13 21:22
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Fourth Quarter 2025
Chicago Atlantic BDC, Inc. announced a $0.34 per share cash dividend for the quarter ending December 31, 2025. The record date is December 31, 2025, and the payment date is January 15, 2026. The company has a dividend reinvestment plan (DRIP), which automatically reinvests dividends into additional shares unless shareholders opt out. Shareholders should contact their brokers to receive cash dividends. The company focuses on maximizing risk-adjust...
11-13 12:00
Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations
Zipalertinib shows 31% intracranial response and good tolerability in CNS-involved EGFR-mutated lung cancer, data presented at ESMO 2025.
10-14 00:46
固态电池龙头斩获全球顶级客户长订单！| 盘后公告精选
固态电池龙头斩获全球顶级客户超长订单，电解液供应协议锁定未来五年需求；半导体存储企业启动港股上市计划；又有药企创新药获美国FDA临床试验批准……今日盘后有哪些值得关注的公告？
09-22 20:55
Taiho Oncology And Cullinan Therapeutics Report 27% Response Rate In REZILIENT1 And 30% Response Rate In REZILIENT2 Lung Cancer Trial
Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced new data from the REZILIENT1 and REZILIENT2 trials of zipalertinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced or metastatic
09-09 17:49
